apollo
logo
0Login
Introducing Our Latest Arrival!
Diziquit-MD 20/40 Tablet 10's

Diziquit-MD 20/40 Tablet 10's

Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Vanprom Lifesciences Pvt Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-25

for this medicine

About Diziquit-MD 20/40 Tablet

Diziquit-MD 20/40 Tablet belongs to a group of anti-vertigo drugs used to treat the symptoms of vertigo, such as dizziness, spinning sensation, nausea, and vomiting. Diziquit-MD 20/40 Tablet can help you to carry out daily activities that are difficult when you have vertigo. Vertigo is a sudden external or internal spinning sensation that causes dizziness. It creates a false sense that you or your surroundings are moving or spinning.

Diziquit-MD 20/40 Tablet contains Cinnarizine (a calcium antagonist) and Dimenhydrinate (an antihistamine). Cinnarizine prevents the narrowing of the blood vessels in the ear, improving blood flow. Dimenhydrinate works by blocking the action of a chemical messenger known as histamine, thereby preventing problems with loss of balance. Together, Diziquit-MD 20/40 Tablet helps reduce the symptoms of vertigo.

Depending on your medical condition, you are advised to take Diziquit-MD 20/40 Tablet for as long as your doctor has prescribed it for you. Sometimes, you may experience certain common side effects, such as drowsiness, dry mouth, stomach pain, and headache. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if you experience these side effects persistently.

Consult your doctor if you are pregnant or breastfeeding. Diziquit-MD 20/40 Tablet may cause drowsiness and sleepiness, so drive only if alert. Diziquit-MD 20/40 Tablet is not recommended for children below 18 years as safety and effectiveness have not been established. Avoid consuming alcohol with Diziquit-MD 20/40 Tablet as it could lead to increased drowsiness. Inform your doctor about all your medicines and health conditions to rule out unpleasant side effects.

Uses of Diziquit-MD 20/40 Tablet

Diziquit-MD 20/40 Tablet is used to treat Vertigo.

Medicinal Benefits

Diziquit-MD 20/40 Tablet contains Cinnarizine and Dimenhydrinate. Diziquit-MD 20/40 Tablet belongs to a group of medicines called anti-vertigo drugs indicated for the symptomatic treatment of vertigo. Cinnarizine is a calcium antagonist that prevents the narrowing of the ear's blood vessels; this helps improve the blood flow in the ear. Dimenhydrinate is an antihistamine that blocks a chemical messenger known as histamine, thereby preventing problems with loss of balance. Together, Diziquit-MD 20/40 Tablet helps in reducing the symptoms of vertigo, such as dizziness and nausea. Diziquit-MD 20/40 Tablet can help you to carry out daily activities that are difficult when you have vertigo.

Directions for Use

Take it with food to prevent indigestion. Swallow it as a whole with a glass of water; do not chew or break it.Mouth dissolving tablet: Place the tablet on the tongue and let it dissolve or disintegrate in the mouth without water.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Diziquit-MD 20/40 Tablet

  • Drowsiness
  • Stomach pain
  • Headache
  • Dry mouth

Drug Warnings

Do not take Diziquit-MD 20/40 Tablet if you are allergic to any of its contents; if you have/had angle-closure glaucoma, epilepsy, increased pressure in the brain due to tumour, urination difficulties due to prostate problems, liver or kidney failure, and alcohol abuse. Inform your doctor if you have low or high blood pressure, glaucoma, obstruction in the bowels, overactive thyroid, severe heart disease, and Parkinson's disease. Consult your doctor if you are pregnant or breastfeeding. Diziquit-MD 20/40 Tablet may cause drowsiness and sleepiness, so drive only if you are alert. Diziquit-MD 20/40 Tablet is not recommended for children below 18 years as safety and effectiveness have not been established. Avoid consuming alcohol with Diziquit-MD 20/40 Tablet as it could lead to increased drowsiness.

Drug Interactions

Drug-Drug Interactions: Diziquit-MD 20/40 Tablet may interact with narcotic analgesics (morphine), anti-cholinergic (atropine), adrenergic receptor agonists (ephedrine), anti-cancer (procarbazine), barbiturates, anti-depressants, and anti-hypertensive drugs.

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: Inform your doctor if you have angle-closure glaucoma, epilepsy/fits, increased pressure in the brain due to tumour, urination difficulties due to prostate problems, liver or kidney failure, low or high blood pressure, glaucoma, obstruction in the bowels, overactive thyroid, severe heart disease, or Parkinson disease.

Drug-Drug Interactions Checker List

  • MORPHINE
  • ATROPINE
  • EPHEDRINE
  • PROCARBAZINE

Habit Forming

No

Diet & Lifestyle Advise

  • Replace regular salt with low-sodium salt, as sodium may aggravate vertigo.
  • Avoid foods rich in sodium, such as soy sauce, chips, popcorn, cheese, canned foods, and pickles.
  • Avoid fluids containing large amounts of sugar and salt, such as soda or concentrated juices. Instead, drink water, milk, and low-sugar fruit juices.
  • Limit salt and sugar intake.
  • Maintain a healthy diet and exercise regularly, as it helps improve overall health and boosts self-esteem.
  • Perform meditation and yoga. This helps in relieving stress and provides relaxation.
  • Follow a regular sleep pattern to improve the amount and quality of sleep you get.
  • Avoid smoking, alcohol, and caffeinated drinks.
  • Learn relaxation skills as they help in reducing stress.

Disease/Condition Glossary

Vertigo: Vertigo is a sudden external or internal spinning sensation that causes dizziness. It creates a false sense that you or your surroundings are moving or spinning. Vertigo is not the same as light-headedness, but it might feel similar to motion sickness. Vertigo occurs due to problems in the brain or inner ear. The main causes of vertigo are migraine, benign paroxysmal positional vertigo, infection, head injury, bleeding in the brain, stroke, tumour or Meniere’s disease. The vertigo symptoms include increased sweating, nausea, vomiting, headache, loss of balance, and feeling that things are spinning or moving.

bannner image

Alcohol

Unsafe

Avoid consumption of alcohol while taking Diziquit-MD 20/40 Tablet as it may cause increased drowsiness.

bannner image

Pregnancy

Caution

Please consult your doctor before taking Diziquit-MD 20/40 Tablet if you are pregnant; your doctor will prescribe Diziquit-MD 20/40 Tablet if the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

Diziquit-MD 20/40 Tablet may pass into breastmilk. Please consult your doctor before taking Diziquit-MD 20/40 Tablet ; your doctor will decide whether Diziquit-MD 20/40 Tablet can be taken by breastfeeding mothers or not.

bannner image

Driving

Caution

Diziquit-MD 20/40 Tablet may cause drowsiness and sleepiness. Do not drive or operate machinery unless you are alert.

bannner image

Liver

Unsafe

Diziquit-MD 20/40 Tablet should not be taken by patients suffering from liver failure. Please consult your doctor if you have a liver impairment or any concerns regarding this.

bannner image

Kidney

Caution

Diziquit-MD 20/40 Tablet should not be taken by patients suffering from kidney failure. Please consult your doctor if you have kidney impairment or any concerns regarding this.

bannner image

Children

Unsafe

Diziquit-MD 20/40 Tablet is not recommended for children below 18 years as the safety and effectiveness were not established.

Country of origin

India

Manufacturer/Marketer address

Gc Complex, 1St Floor, Jwala Heri Market, Paschim Vihar, New Delhi, Delhi - 110063, India
Other Info - DIZ0087

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Diziquit-MD 20/40 Tablet is used to treat the symptoms of vertigo, such as dizziness, spinning sensation, nausea, and vomiting.
Diziquit-MD 20/40 Tablet contains Cinnarizine and Dimenhydrinate. Cinnarizine prevents the narrowing of the blood vessels in the ear; this improves the blood flow in the ear. Dimenhydrinate works by blocking the action of a chemical messenger known as histamine, thus prevents problems with loss of balance.
Dry mouth could be a side-effect of Diziquit-MD 20/40 Tablet . Limiting caffeine intake, avoiding smoking and mouthwashes containing alcohol, drinking water regularly, and chewing sugar-free gum/candy might stimulate saliva and prevent drying of the mouth.
Talk to your doctor before taking Diziquit-MD 20/40 Tablet with anti-hypertensive medicines along with Diziquit-MD 20/40 Tablet as Diziquit-MD 20/40 Tablet might lower their effect. Regular monitoring of blood pressure levels is advised while taking Diziquit-MD 20/40 Tablet .
Please do not stop taking Diziquit-MD 20/40 Tablet on your own as it might cause recurring symptoms. Continue taking Diziquit-MD 20/40 Tablet for as long as your doctor prescribes it. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Diziquit-MD 20/40 Tablet .
Consult your doctor before taking Diziquit-MD 20/40 Tablet if you have glaucoma (raised pressure in the eye). Do not take Diziquit-MD 20/40 Tablet if you have angle-closure glaucoma (a specific type of eye disease).
Patients should not take Diziquit-MD 20/40 Tablet with pre-existing extrapyramidal movement disorders such as Parkinson’s disease.
Diziquit-MD 20/40 Tablet may cause side effects, such as drowsiness, dry mouth, stomach pain, and headache. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if you experience these side effects persistently.
Yes, Diziquit-MD 20/40 Tablet may cause drowsiness. Therefore, avoid driving or operating machinery if you experience drowsiness.
Diziquit-MD 20/40 Tablet may cause indigestion. Taking Diziquit-MD 20/40 Tablet with or after food may help prevent indigestion. Eat smaller meal portions instead of larger meals. Avoid alcohol, caffeine, and foods that may trigger indigestion.
Diziquit-MD 20/40 Tablet is contraindicated in people who are allergic to any of its components, people who have/had angle-closure glaucoma, epilepsy, increased pressure in the brain due to tumour, urination difficulties due to prostate problems, liver or kidney failure, and alcohol abuse.
Taking too much of this medicine may lead to an overdose. The symptoms of overdose include extreme tiredness, dizziness, shakiness, dry mouth, headache, fever, sweat, fast heart rate, dilated pupils or urinary retention. If you suspect you have taken an overdose or notice signs of overdose, please consult a doctor immediately.
If you miss a dose of Diziquit-MD 20/40 Tablet take it as soon as you remember. However, if it is almost time for the scheduled dose, skip the missed dose and take the next dose at the scheduled time.
Store Diziquit-MD 20/40 Tablet at room temperature, in a dry place. Keep out of sight and reach of children.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.